Table 3.
Characteristic | Time from symptoms onset | p value | |
---|---|---|---|
< 7 days (n = 294) | ≥ 7 days (n = 365) | ||
Radiological score, median (IQR) | |||
Qure AI score | 25 (0–44) | 31 (15–44.5) | 0.031 |
RALE score | 5 (2–12) | 6 (3–13) | 0.014 |
Type of opacity, n (%) | |||
Consolidation | 182 (61.9) | 249 (68.2) | 0.090 |
Hazy opacities | 64 (21.8) | 75 (20.5) | 0.703 |
Opacities’ distribution predominance, n (%) | |||
Peripheral | 117 (39.8) | 193 (52.9) | 0.001 |
Peri-hilar | 33 (11.2) | 30 (8.2) | 0.192 |
Upper quadrants | 17 (5.8) | 24 (6.6) | 0.675 |
Lower quadrants | 70 (23.8) | 95 (26.0) | 0.514 |
Hilar enlargement, n (%) | 61 (20.7) | 77 (21.1) | 0.913 |
Pleural effusion, n (%) | 24 (8.2) | 19 (5.2) | 0.126 |
IQR, interquartile range; RALE, Radiographic Assessment of Lung Edema